The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +91 22 2265 9969
Mumbai, New Delhi

The firm

Brus Chambers is a specialised Indian law firm with an international perspective and historical strength in the shipping and projects (infrastructure and construction, oil and gas) work. The firm has unrivalled expertise in corporate, arbitration and litigation, P&I and marine insurance, banking and finance, real estate. Across each of these sectors, the firm offers a fully comprehensive service.

Sector focus has been pivotal to Brus Chambers’ success, borne out of the fact that it is a market leader in the sectors in which it is active.

Areas of practice

The firm, with highly qualified partners, is a dominant force within the Indian shipping market and is especially noted for its experience in ship arrests, P&I settlements, shipping finance, buying and selling of ships, disputes pertaining to contracts, cargo claims, charter parties, mortgage, bill of lading, damages, bunker and necessary supplies, ship building, repairs, ownership or possession, lay time and demurrage, collisions, marine insurance and finance and shipping arbitration and litigation. As ‘a clear market leader’, Brus Chambers acts on wet and dry shipping transactional and dispute matters.

Brus Chambers is one of the leading and probably pre-eminent, Indian firms for project work and maintains one of India’s top infrastructure and construction projects and oil, gas, energy and resources practices. It provides a ‘very commercial approach’. The firm has an enviable reputation for corporate work.

Managing and practising partner Shrikant Hathi is a specialist in shipping and projects, with a particular focus on ship arrest and all aspects of shipping disputes and transactional work, and is renowned for his expertise in wet and dry shipping advice. He also advises on infrastructure and construction, oil, gas and natural resources. He is an excellent strategist and has for many years had an unparalleled reputation in shipping and project works among international clients and legal peers.

Uttam Hathi specialises in corporate work, regulatory compliances, foreign investment in India, establishment of joint ventures, subsidiaries, mergers and acquisitions, corporate structuring and restructuring and corporate advisory.

Binita Hathi specialises in dispute resolution and has extensive experience in resolving international and domestic disputes through litigation and arbitration and is also known for negotiating amicable settlement between the parties. She has ‘sound knowledge’ and offers ‘practical solutions’ to clients, and has notable expertise in commercial litigation and arbitration matters and is praised for her multi-jurisdictional reach. Her strength in shipping, projects, commercial disputes is leveraged in settling related disputes, and she has developed a reputation for settlement of disputes. She also heads the firm’s international commercial arbitration team.

Natasha Sailopal and Poonam Sharma Baloni are excellent in recovery of crew claims and P&I settlements within shipping. Both also excel at contractual law, international arbitration and enforcement of foreign decree arbitral award in India.

The firm’s other partners attend to corporate, commercial, infrastructure projects, real estate, banking and finance. Ms Afia SenGupta heads the subsidiary law firm Brus Chambers LLC in the Unites States of America.

Contact Shrikant Hathi (managing partner,

Languages English

Other offices Port and capital city in all states of India

Number of lawyers 22

at this office 12

Above material supplied by BRUS CHAMBERS, Advocates & Solicitors.

Legal Developments in India

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

  • Post Marketing Surveillance of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India. The regulatory framework for conducting clinical trials of drugs is provided under the Drugs and Cosmetics Act, 1940 (“ Act ”) and the Drugs and Cosmetics Rules, 1945 (“ Rules ”). Further, Part X-A and Schedule Y of the Rules specifically deal with the statutory provisions applicable for clinical trial of drugs in India. Schedule Y divides Clinical trial of drugs into 4 Phases, namely, Human Pharmacology (Phase-I), Therapeutic exploratory trials (Phase-II), Therapeutic confirmatory trials (Phase III) and Post Marketing Trials (Phase-IV).
  • Protection of Biotechnology under Indian Laws

    According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises (ABLE) and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year. Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY2014; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY2015. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R & D activities and strong government initiatives ( )
  • Cabinet Approves India’s IPR Policy - “Creative India; Innovative India: रचनात्म??

    The Union Cabinet on 13 May 2016 approved the National Intellectual Property Right (IPR) policy roadmap ( ) to foster creativity and innovation, promote entrepreneurship and enhance socio development, enhance access to healthcare, food security and environmental protection. The Policy recognizes the abundance of creative and innovative energies that flow in India, and the need to tap into and channelize these energies towards a better and brighter future for all.
  • Real Estate - India

    Real Estate - India
  • SEBI’s Jurisdiction | Analysis of the Supreme Court judgment in the Sahara case

    The Securities and Exchange Board of India (SEBI) is responsible for investor protection and development and regulation of the securities market in India. The scope of SEBI’s jurisdiction over the issue of securities by public companies is an important issue. This issue was recently considered by the Supreme Court in Sahara India Real Estate Corporation Ltd. and Ors. v. Securities and Exchange Board of India and Anr., MANU/SC/0702/2012; (2012) 8 SCALE 101. This article analyses this judgment and its implications.
  • Mainstreaming the Alternative: Issuance of NCDs

    Debt financing is a significant means for corporates to raise capital. Indian regulators have taken a number of steps to deepen the Indian debt market. Permission has been granted to foreign institutional investors (FIIs) and qualified foreign investors (QFIs) to invest in non-convertible debentures (NCDs) issued by Indian companies. This article summarises the legal and regulatory requirements for Indian companies to issue NCDs to FIIs and QFIs.
  • Options – Not a Part of History Yet

    At the time when India is completing two decades of the economic liberalization there are several laurels which the policymakers can boast of.   The path-breaking shift from the license-raj to a regime focusing on regulation introduced by the Government of India in the landmark year 1991 have been continued through further economic reforms and the same has also found support from the regulators and the market players.
  • Liberalization Back on Track with the Relaxation of Share Transfer Norms

    Soon after the rollback of the much criticized aspect of the Consolidated Foreign Direct Investment policy dated October 1, 2011 which treated foreign investments in Indian securities as external commercial borrowings in case such investments conferred options on the foreign investors, the policy makers have brought more good news for the investor community.
  • Franchising in India

    In the last two decades, India has witnessed a sea change in its foreign investment policy resulting in it being one of the most preferred investment destinations. With growing globalisation and liberalisation, brand awareness has been created in the Indian masses and today India is the one of the biggest and fastest emerging markets for various businesses across the world. Being geographically vast and culturally diverse, India offers the most favorable franchising environment with a huge consumer market. Franchising in this respect has managed to pick up as a successful business module for local companies in India.